New Treatments

In most cases, hormone therapy can be restarted soon after endometriosis surgery—often once we’re confident you’re past the immediate post-op healing phase and any bleeding or surgical-site irritation is settling. The right timing depends on what procedure you had (simple excision vs bowel/bladder work), how your recovery is going, and your goals (pain control, cycle management, fertility planning). We also consider what hormone you’re restarting, since options like continuous birth control or progestin-based therapy are used differently than deeper estrogen-suppressing medications.

It’s also important to frame why you’re restarting: hormones may help quiet symptoms and can be part of a strategy to reduce recurrence risk, but they don’t “heal” endometriosis on their own. If you’re considering stronger estrogen-suppressing medications (like GnRH analogs), we plan that thoughtfully because they’re not designed for long-term use and can carry meaningful side effects. If you tell us what you were on before surgery and what symptoms you’re trying to prevent, our team can help you choose a timeline and post-op plan that supports healing and longer-lasting relief—reach out to schedule a follow-up or consultation so we can tailor it to you.

Endometriosis doesn’t currently have a proven permanent “cure,” but many people can achieve major, lasting symptom improvement. The goal is typically durable relief and disease control—what many patients describe as remission—while protecting long-term pelvic and reproductive health.

In our practice, excision surgery aims to remove all visible endometriosis, which can significantly reduce pain and may improve fertility outcomes for some patients. Hormonal therapies don’t remove lesions, but they can suppress activity and help manage symptoms, either on their own or as part of a longer-term plan. Because endometriosis can behave differently from person to person, the most effective path usually involves an individualized strategy and follow-up—if you’d like, you can reach out to schedule a consultation with our team to discuss your goals and options.

Researchers are studying new, non-hormonal treatments for endometriosis that aim to treat the disease biology itself—not just suppress cycles. Current trials include medications designed to reduce inflammation, calm nerve sensitization (pain signaling), limit new blood vessel growth (angiogenesis), and address scarring and fibrosis.

There’s also growing interest in how the microbiome and immune system may influence symptoms and progression, which could shape future therapies. While a few approaches look promising, most are still experimental and not widely available outside of clinical trials. If you’re curious about what’s in the pipeline and what may be appropriate for your situation, our team can help you understand where emerging therapies fit alongside proven options like expert excision surgery and individualized medical management.

A well-designed clinical trial can be a good fit if you want access to an investigational therapy and are comfortable contributing to research that may improve endometriosis care. At the same time, trials often involve randomization (and sometimes placebo), stricter protocols, additional visits, and rules about what other treatments you can use during the study.

Before enrolling, it’s important to understand exactly what the study requires and how it could affect your overall plan—especially if you’re considering surgery, trying to preserve or pursue fertility, or managing symptoms with medications. Our team can help you weigh the potential benefits against the time commitment, risks, and likelihood that the trial will answer the questions that matter most for your case, and help you think through what to ask the study coordinators before you decide.

Medications don’t cure endometriosis, and they typically don’t eliminate endometriosis lesions. What they can do is quiet the hormonal signals that stimulate lesions and reduce inflammation, which often improves pain and can make the disease feel “less active” while you’re on treatment.

Because the underlying tissue usually isn’t removed, symptoms commonly return when medication is stopped. For some patients, medical suppression can be a helpful bridge to surgery or a way to manage symptoms when surgery isn’t the right fit right now. After complete excision, we may still consider hormonal suppression in select cases to help lower the chance of recurrent symptoms, and our team can help you weigh those options based on your goals and history.

A safe way to start is by using reputable trial registries (such as ClinicalTrials.gov) to confirm a study is real and to review the basics: the trial phase, what treatment is being tested, the primary outcomes, and the eligibility criteria. We also encourage you to look closely at what participation actually involves—extra visits, imaging, biopsies, medication changes, or washout periods—so you can weigh the time and symptom impact alongside potential benefit. Many trials do cover study-related costs, but coverage varies, so it’s important to clarify what is paid for, what might be billed to insurance, and any travel or time-off burdens.

To judge the “hype,” focus on the quality of the evidence rather than headlines or social media summaries. Peer-reviewed publication helps, but we also look for whether the study design and sample size are strong enough to support the claims and whether the outcomes are truly meaningful for patients (pain, daily function, and quality of life—not just lab markers). If you’d like, our team can help you interpret a trial listing or a published paper in the context of your symptoms and goals and discuss whether a study is a reasonable fit for you.

Some emerging therapies are being studied with the goal of reducing endometriosis symptoms without prolonged ovarian suppression, which may matter if you’re trying to conceive or planning IVF. That said, many investigational options are available only through clinical trials, and trials often require contraception and specific “washout” windows that can affect your treatment timeline.

If fertility is a priority, the key is aligning any new-treatment plan with your reproductive goals and any planned egg retrieval or embryo transfer. Our team can help you weigh potential benefits, timing constraints, and how a given option might fit alongside fertility treatment, and we can coordinate next steps with your fertility care when needed.

Researchers are actively studying non-hormonal ways to reduce endometriosis pain by targeting the biology that drives inflammation and pain signaling rather than suppressing ovarian function. This includes medications aimed at immune and inflammatory pathways, drugs that block specific ion channels involved in nerve sensitivity (including TRP pathways), and therapies that interrupt nerve-growth signaling that may contribute to chronic pelvic pain.

Most of these options are still in early-stage trials, which means they aren’t widely available yet and the full picture on long-term effectiveness and safety is still emerging. If you’re interested in non-hormonal strategies, our team can help you understand where investigational therapies fit in the bigger plan—especially when pain may also be coming from treatable sources like deep disease, adhesions, or adenomyosis—and discuss next steps during a consultation.